Outcomes in Congenital Heart Disease Patients with Right Ventricular Volume Overload


About this study

The purpose of this study is to describe hemodynamics and clinical outcomes in patients with right ventricular volume overload (RVVO). 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

Inclusion Criteria:

The following categories of patients will be enrolled in the study:

  • Atrial septal defect and anomalous pulmonary venous drainage
  • Tricuspid regurgitation (Ebstein's anomaly and tricuspid valve dysplasia)
  • Pulmonary regurgitation (tetralogy of Fallot and pulmonic stenosis

Exclusion Criteria: 

  • Less than 2 years of follow-up at Mayo


Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Alexander Egbe, M.B.B.S.

Contact us for the latest status

Contact information:

Alexander Egbe M.B.B.S.



More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer